Works matching IS 10781552 AND DT 2020 AND VI 26 AND IP 7


Results: 40
    1

    Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1676, doi. 10.1177/1078155220953198
    By:
    • Başcı, Semih;
    • Ata, Naim;
    • Altuntaş, Fevzi;
    • Yiğenoğlu, Tuğçe Nur;
    • Dal, Mehmet Sinan;
    • Korkmaz, Serdal;
    • Namdaroğlu, Sinem;
    • Baştürk, Abdülkadir;
    • Hacıbekiroğlu, Tuba;
    • Doğu, Mehmet Hilmi;
    • Berber, İlhami;
    • Dal, Kürşat;
    • Erkurt, Mehmet Ali;
    • Turgut, Burhan;
    • Çağlayan, Murat;
    • Ayvalı, Mustafa Okan;
    • Çelik, Osman;
    • Ülgü, Mustafa Mahir;
    • Birinci, Şuayip
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Management of skin adverse reactions in oncology.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1703, doi. 10.1177/1078155220936341
    By:
    • Silva, Diva;
    • Gomes, Ana;
    • MS Lobo, José;
    • Almeida, Vera;
    • Almeida, Isabel F
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1583, doi. 10.1177/1078155219900908
    By:
    • Hizal, Mutlu;
    • Sendur, Mehmet AN;
    • Yasar, Hatime Arzu;
    • Bir Yucel, Kadriye;
    • Arslan, Cagatay;
    • Ucar, Gokhan;
    • Karakaya, Serdar;
    • Taban, Hakan;
    • Kucukarda, Ahmet;
    • Erturk, Ismail;
    • Bilgin, Burak;
    • Yıldırım, Nuriye;
    • Demirci, Umut;
    • Kılıckap, Saadettin;
    • Cicin, Irfan;
    • Karadurmus, Nuri;
    • Yalcin, Bulent;
    • Ürün, Yüksel
    Publication type:
    Article
    38
    39
    40